Vanguard Personalized Indexing Management, LLC Cabaletta Bio, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $8.6 Billion
- Q2 2025
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 24,948 shares of CABA stock, worth $68,357. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,948
Previous 19,379
28.74%
Holding current value
$68,357
Previous $26,000
42.31%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding CABA
# of Institutions
92Shares Held
79.6MCall Options Held
406KPut Options Held
90.9K-
Bain Capital Life Sciences Investors, LLC Boston, MA9.68MShares$26.5 Million4.41% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA8.83MShares$24.2 Million0.02% of portfolio
-
Jennison Associates LLC8.5MShares$23.3 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.79MShares$18.6 Million0.01% of portfolio
-
Cormorant Asset Management, LP Boston, MA5MShares$13.7 Million0.77% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $79.5M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...